The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $150.97

Today's change-1.85 -1.21%
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $150.97

Today's change-1.85 -1.21%
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.

Jazz Pharmaceuticals PLC down (U.S.)$1.85

Jazz Pharmaceuticals PLC closed lower Friday, dropping (U.S.)$1.85 or 1.21% to (U.S.)$150.97. Over the last five days, shares have gained 6.35% and 7.41% year to date. Shares have underperformed the S&P 500 by 23.91% during the last year.

Key company metrics

  • Open(U.S.) $152.82
  • Previous close(U.S.) $152.82
  • High(U.S.) $153.73
  • Low(U.S.) $149.45
  • Bid / Ask(U.S.) $111.14 / (U.S.) $159.74
  • YTD % change+7.41%
  • Volume1,288,632
  • Average volume (10-day)972,097
  • Average volume (1-month)940,696
  • Average volume (3-month)829,210
  • 52-week range(U.S.) $108.50 to (U.S.) $194.73
  • Beta0.81
  • Trailing P/E28.53×
  • P/E 1 year forward13.55×
  • Forward PEG0.74×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.29
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.21%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue336341341334
Total other revenue--------
Total revenue336341341334
Gross profit313317312312
Total cost of revenue23242822
Total operating expense215234209197
Selling / general / administrative129124104107
Research & development40295128
Depreciation / amortization23242624
Interest expense (income), net operating--------
Unusual expense (income)--33017
Other operating expenses, total--------
Operating income121107132136
Interest income (expense), net non-operating-12-12-13-16
Gain (loss) on sale of assets--------
Other--------
Income before tax10897118119
Income after tax74838888
Income tax, total34143031
Net income74838888
Total adjustments to net income--------
Net income before extra. items74838888
Minority interest--000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items74838888
Inc. avail. to common incl. extra. items74838888
Diluted net income74838888
Dilution adjustment0------
Diluted weighted average shares62636363
Diluted EPS excluding extraordinary itemsvalue per share1.191.321.391.40
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.121.571.391.59